Tashkent [Uzbekistan], October 11 (ANI): Philip Morris International (PMI) is providing a spread of much less dangerous options for people who smoke and has invested USD 16 billion in analysis, growth and commercialization of such merchandise, Dr Tomoko Iida, Senior Director, Scientific Engagement, South Asia, Indochina, CIS and Middle East & Africa, Philip Morris International, stated.
“We have invested 16 billion dollars in research, development and commercialization of these less harmful products,” she stated, including that “science has shown us that smoking cigarettes can cause diseases, and it became clear to everyone.”
She additional added that this was the place the corporate determined that it wanted to rework itself, in a world the place greater than 1 billion people who smoke nonetheless exist.
Speaking with ANI on the Technovation occasion within the capital of Uzbekistan, she stated PMI’s resolution to rework its enterprise was primarily based on scientific proof concerning the well being dangers related to cigarette smoking and the necessity to deal with the continued presence of people who smoke globally.
“Science has shown us that smoking cigarettes can cause diseases,” she stated. We are the corporate who know concerning the people who smoke very nicely. We learn about tobacco leaves, and we’ve got geared up ourselves with the science and analysis,” she said. Iida said nicotine was often misunderstood and stressed that while it is addictive and not risk-free, it is not the primary cause of smoking-related diseases.
“Nicotine, though it is not risk-free and it is addictive, is just not the primary or major reason behind smoking-related illnesses,” she said.
She said tobacco harm reduction involved offering less harmful alternatives to adult smokers who continued to smoke.
“In a really perfect world, if each smoker quits smoking, that’s the finest. But everyone knows that isn’t all the time the case,” Iida said.
According to her, more than 60 per cent of legal-age smokers do not want to quit smoking, making alternatives an important part of the company’s tobacco harm reduction approach. “If you take a look at nations like Sweden and Japan, we’ve got already began to see the impact of getting these options on public well being, and I hope we will try this in your nation, in India, as nicely,” she said.
Iida said the approach to tobacco-related issues had to take into account the different cultural, social and economic contexts of individual countries.
“Each nation has a unique cultural sensitivity, a unique context in terms of the tobacco subject,” she said.
She cited Japan as an example, saying smoking prevalence there had fallen from around 20 per cent in 2014 to around 10 per cent currently.
“In Japan, it took us 10 years, however smoking prevalence has practically halved in 10 years,” she said.
Iida attributed the change to the availability, accessibility and affordability of less harmful alternatives for legal-age smokers, saying smokers gradually came to understand the functional benefits of switching to such products.
She said tobacco-growing countries could also require a different approach, as tobacco agriculture can be linked to employment and the economy.
“In different nations, as I stated, if tobacco agriculture is a really large enterprise or it employs lots of people, then we’ve got to assume: Is there another different crop that they’ll develop or different means of utilizing tobacco leaves for merchandise apart from cigarettes?” she said.
On regulation, Iida said governments and regulators needed to work with industry to create frameworks that accommodate innovation and ensure that alternatives are available and accessible to consumers, and that such products are regulated based on scientific evidence.
“The regulation needs to be there to accommodate the innovation,” she said.
She also stressed the importance of consumer acceptance, saying taste, satisfaction, aroma and ritual could influence whether smokers switch from cigarettes.
“Consumer acceptance is simply as essential,” she said.
Iida said 42 per cent of PMI’s net revenue currently came from less harmful alternatives and that the company had a vision of taking the share to two-thirds by 2030.
“Our imaginative and prescient is to construct a smoke-free future globally,” she said.
She said that in Japan, where PMI has worked on less harmful alternatives for the past 12 years, more than 75 per cent of the company’s net revenue already came from such alternatives, adding that the company might very soon be known as a non-cigarette company.
Iida also distinguished heated tobacco products from e-vapor products, saying heated tobacco products use tobacco leaves and should not be treated as the same as vaping products.
She said PMI’s experience across South Asia, the Commonwealth of Independent States (CIS), the Middle East and Africa had reinforced the importance of adapting engagement with scientists, healthcare professionals and government officials to local contexts.
“We are actually dedicated to construct a smoke-free future,” Iida said, adding that she hoped this could happen everywhere “very, very quickly, together with India”. (ANI)